Cannabis use among cancer survivors in the United States:
Analysis of a nationally representative sample

J 2021

Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample

DO, Elizabeth K., Albert KŠIŇAN, Sunny J KIM, Egidio G. DEL FABBRO, Bernard F. FUEMMELER et. al.

Basic information

Original name

Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample

Authors

DO, Elizabeth K., Albert KŠIŇAN, Sunny J KIM, Egidio G. DEL FABBRO and Bernard F. FUEMMELER

Edition

Cancer, HOBOKEN, WILEY, 2021, 0008-543X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 6.921

DOI

http://dx.doi.org/10.1002/cncr.33794

UT WoS

000674914100001

Keywords in English

cancer; cannabis; Population Assessment of Tobacco and Health (PATH)

Abstract

V originále

Background Research on cannabis use among those with a history of cancer is limited. Methods Prevalence of past-year cannabis use among individuals with and without a cancer history and predictors of use within these 2 groups were determined using data from the Population Assessment of Tobacco and Health study, a nationally representative, longitudinal survey conducted in the United States (waves 1-4; 2013-2018). Discrete time survival analyses were used to estimate baseline (wave 1) predictors (physical health status, mental health status, pain, and demographic variables) on past-year engagement with cannabis within individuals who reported a cancer diagnosis at wave 1 (n = 1022) and individuals who reported never having cancer at any wave (n = 19,702). Results At the most recent survey, 8% of cancer survivors reported past-year cannabis use, compared with 15% of those without a cancer history. Across 4 time points, an estimated 3.8% of cancer survivors engaged with cannabis, as compared to 6.5% of those without a cancer history. Across both groups, older age and having health insurance were associated with lower likelihood of engaging in cannabis use, whereas greater levels of pain were associated with higher likelihood of engaging in cannabis use. Among those without a cancer history, being female, White, and having better mental health status were associated with lower likelihood of engaging in cannabis use. Conclusions Although cannabis use prevalence is lower among cancer survivors, the reasons for use are not markedly different from those without a cancer history. Continued monitoring of use, reasons for use, and harms or benefits is warranted. Lay Summary Results from this study, which uses data from the Population Assessment of Tobacco and Health Study, indicate that cannabis use is generally increasing across cancer survivors and those without a history of cancer. Cancer survivors are using cannabis at slightly lower rates than those without a history of cancer. Factors related to pain seem to be more prevalent in cancer populations relative to the general population, and could be contributing to cannabis use within cancer survivor populations.

Citovat

DO, Elizabeth K., Albert KŠIŇAN, Sunny J KIM, Egidio G. DEL FABBRO and Bernard F. FUEMMELER. Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample. Cancer. HOBOKEN: WILEY, 2021, 10 pp. ISSN 0008-543X. Available from: https://dx.doi.org/10.1002/cncr.33794.

@article{1790650,
   author = {Do, Elizabeth K. and Kšiňan, Albert and Kim, Sunny J and Del Fabbro, Egidio G. and Fuemmeler, Bernard F.},
   article_location = {HOBOKEN},
   doi = {http://dx.doi.org/10.1002/cncr.33794},
   keywords = {cancer; cannabis; Population Assessment of Tobacco and Health (PATH)},
   language = {eng},
   issn = {0008-543X},
   journal = {Cancer},
   title = {Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample},
   year = {2021}
}

TY  - JOUR
ID  - 1790650
AU  - Do, Elizabeth K. - Kšiňan, Albert - Kim, Sunny J - Del Fabbro, Egidio G. - Fuemmeler, Bernard F.
PY  - 2021
TI  - Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample
JF  - Cancer
PB  - WILEY
SN  - 0008543X
KW  - cancer
KW  - cannabis
KW  - Population Assessment of Tobacco and Health (PATH)
N2  - Background Research on cannabis use among those with a history of cancer is limited. Methods Prevalence of past-year cannabis use among individuals with and without a cancer history and predictors of use within these 2 groups were determined using data from the Population Assessment of Tobacco and Health study, a nationally representative, longitudinal survey conducted in the United States (waves 1-4; 2013-2018). Discrete time survival analyses were used to estimate baseline (wave 1) predictors (physical health status, mental health status, pain, and demographic variables) on past-year engagement with cannabis within individuals who reported a cancer diagnosis at wave 1 (n = 1022) and individuals who reported never having cancer at any wave (n = 19,702). Results At the most recent survey, 8% of cancer survivors reported past-year cannabis use, compared with 15% of those without a cancer history. Across 4 time points, an estimated 3.8% of cancer survivors engaged with cannabis, as compared to 6.5% of those without a cancer history. Across both groups, older age and having health insurance were associated with lower likelihood of engaging in cannabis use, whereas greater levels of pain were associated with higher likelihood of engaging in cannabis use. Among those without a cancer history, being female, White, and having better mental health status were associated with lower likelihood of engaging in cannabis use. Conclusions Although cannabis use prevalence is lower among cancer survivors, the reasons for use are not markedly different from those without a cancer history. Continued monitoring of use, reasons for use, and harms or benefits is warranted. Lay Summary Results from this study, which uses data from the Population Assessment of Tobacco and Health Study, indicate that cannabis use is generally increasing across cancer survivors and those without a history of cancer. Cancer survivors are using cannabis at slightly lower rates than those without a history of cancer. Factors related to pain seem to be more prevalent in cancer populations relative to the general population, and could be contributing to cannabis use within cancer survivor populations.
ER  -

DO, Elizabeth K., Albert KŠIŇAN, Sunny J KIM, Egidio G. DEL FABBRO and Bernard F. FUEMMELER. Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample. \textit{Cancer}. HOBOKEN: WILEY, 2021, 10 pp. ISSN~0008-543X. Available from: https://dx.doi.org/10.1002/cncr.33794.

Detailed Information on Publication Record